PedAM
Pediatric Disease Annotations & Medicines
| Disease | neuropathy |
| Phenotype | |type 2 diabetes |
| Sentences | 94 |
| PubMedID- 20690070 | Aim: the aim of this prospective study was to evaluate the contribution of the indicator test for sudomotor function neuropad(r) to the early diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus. |
| PubMedID- 26344697 | Aims: this paper aims to investigate whether intraepidermal nerve-fibre density (ienfd) may be used as a marker of the course of neuropathy in patients with type 2 diabetes mellitus. |
| PubMedID- 23775136 | Conclusions: our data suggest a possible association of c332c-genotype of the glyoxalase 1 gene with diabetic neuropathy in type 2 diabetes, supporting the hypothesis that methylglyoxal might be an important mediator of diabetic neuropathy in type 2 diabetes. |
| PubMedID- 21977459 | [16] showed that diabetic neuropathy was associated with retinopathy in type 2 diabetes mellitus. |
| PubMedID- 25579387 | Hyperuricemia was also significantly associated with increased risk of peripheral neuropathy in patients with type 2 diabetes (risk ratio [rr] = 2.83, 95%ci 2.13-3.76, p < 0.00001). |
| PubMedID- 24381764 | In conclusion, the results of the current meta-analysis suggested an association of elements of neuropathy with sas in type 2 diabetes. |
| PubMedID- 26466574 | The aim of this study was to investigate the relationships of serum omentin levels and vascular complications including cardiac autonomic neuropathy (can) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 25720672 | Conclusion: short-term oral vitamin d3 supplementation improved vitamin d status and the symptoms of neuropathy in patients with type 2 diabetes. |
| PubMedID- 24507164 | Effect of aerobic exercise on peripheral nerve functions of population with diabetic peripheral neuropathy in type 2 diabetes: a single blind, parallel group randomized controlled trial. |
| PubMedID- 21341457 | Aim: to study clinical and metabolic risk factors for cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 22519862 | Conclusion: there was a high prevalence of peripheral neuropathy in patients with type 2 diabetes in korea and those patients were far more likely to have complications or co-morbidities. |
| PubMedID- 22111049 | [11] demonstrated an independent association between pulse pressure and hypertension and diabetic peripheral neuropathy in patients with type 2 diabetes. |
| PubMedID- 21873064 | Gait pattern alterations in older adults associated with type 2 diabetes in the absence of peripheral neuropathy--results from the baltimore longitudinal study of aging. |
| PubMedID- 26150192 | The relationship between vitamin d status and cardiac autonomic neuropathy in patients with type 2 diabetes mellitus. |
| PubMedID- 23369667 | [4] used ffi scores to evaluate type 2 diabetes with and without neuropathy and identified that group with neuropathy had worse ffi scores. |
| PubMedID- 23002037 | However, ienfd and corneal nerve morphology have been shown to improve in subjects with impaired glucose tolerance neuropathy (9) and in patients with type 2 diabetes (10), respectively, after improvement in metabolic risk factors. |
| PubMedID- 22242266 | [relationship between left ventricle dysfunction and the development of neuropathy in patients with type 2 diabetes mellitus]. |
| PubMedID- 22346190 | Role of nitrosative and oxidative stress in neuropathy in patients with type 2 diabetes mellitus. |
| PubMedID- 26264399 | We therefore performed a proof-of-concept pilot study to evaluate the effect of exenatide, a glp-1 agonist, on measures of dpn and cardiovascular autonomic neuropathy (can) in patients with type 2 diabetes (t2d). |
| PubMedID- 21515565 | Prevalence of stdr was high and in type 2 diabetes was associated with albuminuria, neuropathy and insulin use. |
| PubMedID- 24843490 | Experience has shown that ala is effective in reducing painful neuropathy in patients with type 2 diabetes. |
| PubMedID- 23650675 | Objective: to identify the association between peripheral vascular disease, and neuropathy in type 2 diabetes mellitus patients from the hospital general de zona no. |
| PubMedID- 23811603 | Objective: we examined the relationship between serum fetuin-a, insulin resistance (ir), metabolic syndrome (ms) and vascular complications including cardiac autonomic neuropathy (can) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 24565211 | Aims: this study aimed to assess the prevalence and electrophysiological features of ulnar entrapment neuropathy in patients with type 2 diabetes mellitus (dm). |
| PubMedID- 22830040 | The aim of this study was to compare sudoscan, a new device to evaluate sweat function (reflecting peripheral small c-fiber status), with conventional measures of peripheral and cardiac neuropathy in patients with type 2 diabetes. |
| PubMedID- 22950060 | Background: the aim of this study was to investigate the influences of visceral adiposity on cardiovascular autonomic neuropathy (can) in patients with type 2 diabetes mellitus. |
| PubMedID- 23465172 | Conclusions: mitochondrial oxidative phosphorylation is impaired only in type 2 diabetes mellitus patients with neuropathy whether or not peripheral arterial disease is present and is associated with the increased proinflammatory state observed in these groups. |
| PubMedID- 22209024 | The purpose of this pilot study was to investigate a possible role for gap-43 in the detection of the early stages of small-fiber neuropathy in patients with type 2 diabetes mellitus (dm2) as compared with a well- established and validated parameter - intra-epidermal nerve fiber density (ienfd) of protein gene product 9.5 (pgp 9.5) immunoreactive intra-epidermal c fibers. |
| PubMedID- 25422773 | Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. |
| PubMedID- 26216366 | Serum cystatin c levels are positively associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes. |
| PubMedID- 20130937 | We evaluated the role of insulin resistance in the pathogenesis of peripheral and autonomic neuropathy in patients with type 2 diabetes. |
| PubMedID- 23275938 | The goal of this study was to determine the relationship between bapwv and diabetic peripheral neuropathy (dpn) in patients with type 2 diabetes. |
| PubMedID- 25349821 | Screening of autonomic neuropathy in patients with type 2 diabetes. |
| PubMedID- 25810640 | Materials and methods: the cytokinesis block micronucleus cytome assay was performed in lymphocyte cultures of 42 type 2 diabetes patients (22 with neuropathy and 20 without neuropathy) and 42 age and sex matched controls. |
| PubMedID- 19716319 | Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of n(varepsilon)-carboxymethyl lysine. |
| PubMedID- 26044207 | Increased aortic stiffness predicts future development and progression of peripheral neuropathy in patients with type 2 diabetes: the rio de janeiro type 2 diabetes cohort study. |
| PubMedID- 25846483 | Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes. |
| PubMedID- 19846797 | Metformin exposure may be an iatrogenic cause for exacerbation of peripheral neuropathy in patients with type 2 diabetes. |
| PubMedID- 24593991 | So, good glycemic control with early and comprehensive neurological investigations for peripheral neuropathy in a patient with type 2 diabetes is necessary to have better management of disease and also decrease related costs. |
| PubMedID- 22723291 | Objectives: to assess the relationship between osa and peripheral neuropathy in patients with type 2 diabetes. |
| PubMedID- 25634425 | Objective: the objective of this study is to assess the frequency of cardiovascular autonomic neuropathy (can) in patients with poorly controlled type 2 diabetes mellitus in pakistan. |
| PubMedID- 22894640 | They showed that omega-3 fatty acids could attenuate the severity of neuropathy in patients with type 2 diabetes mellitus [13,15]. |
| PubMedID- 25387363 | Although erythropoietin ameliorates experimental type 2 diabetes with neuropathy, serious side effects limit its potential clinical use. |
| PubMedID- 22494488 | Prolonged elevated glucose levels contribute to the well-known macrovascular (cardiovascular disease, peripheral vascular disease) and microvascular (nephropathy, retinopathy, neuropathy) complications associated with type 2 diabetes. |
| PubMedID- 24803311 | The impact of the metabolic syndrome on neuropathy in patients with type 2 diabetes may account for the difference between the two types of diabetes and requires further study. |
| PubMedID- 20722677 | Conclusion: this study suggests that the t/a combination treatment is as effective as gabapentin in the treatment of painful diabetic neuropathy in patients with type 2 diabetes. |
| PubMedID- 24719137 | The role of insulin resistance in diabetic neuropathy in koreans with type 2 diabetes mellitus: a 6-year follow-up study. |
| PubMedID- 24959571 | The second study compared the efficacy of tramadol/paracetamol and gabapentin in type 2 diabetes with painful symmetric neuropathy in the lower limbs [110]. |
| PubMedID- 23506430 | Conclusions: a more atherogenic lipid profile such as the triglyceride: hdl cholesterol ratio and a smaller mean ldl cholesterol particle size were related to the prevalence of cardiac autonomic neuropathy in women with type 2 diabetes. |
| PubMedID- 26248423 | [the significance of quantitative temperature sense thresholds in diagnosis of small fibrous sensory neuropathy in patients with type 2 diabetes]. |
Page: 1 2